Arix Bioscience plc
Issue of Ordinary Shares and Total
Voting Rights
Arix Bioscience plc (the "Company") announces that it has
allotted 530,000 new Ordinary Shares to the Arix Bioscience plc
Employee Benefit Trust in order to satisfy awards made under the
Arix Bioscience plc Executive Incentive Plan.
Application has been made for 530,000 new Ordinary Shares to be
admitted to the standard segment of the Official List and to
trading on the Main Market of the London Stock Exchange. The new
Ordinary Shares will rank pari passu with the existing ordinary
shares and it is expected that admission of these new Ordinary
Shares will take place at 8.00 a.m.
on 2 May 2019.
Following the issue of 530,000 shares the Company will have a
total of 135,467,601 ordinary shares of £0.00001 each in issue and
a total number of voting rights in the Company of 135,467,601. The
above figure of 135,467,601 may be used by shareholders as the
denominator for the calculation by which they may determine if they
are required to notify their interest in, or change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information:
Robert
Lyne
Company
Secretary
+44 (0)207 290 1050
- Ends -